[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 4355 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  2d Session
                                S. 4355

    To amend the Controlled Substances Act to prohibit the knowing 
possession of a pill press mold with intent to manufacture in violation 
 of such Act a counterfeit substance in schedule I or II in a capsule, 
    tablet, and other form intended for distribution, and for other 
                               purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 16, 2024

Mr. Cassidy (for himself and Ms. Hassan) introduced the following bill; 
  which was read twice and referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL


 
    To amend the Controlled Substances Act to prohibit the knowing 
possession of a pill press mold with intent to manufacture in violation 
 of such Act a counterfeit substance in schedule I or II in a capsule, 
    tablet, and other form intended for distribution, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Criminalizing Abused Substance 
Templates Act of 2024''.

SEC. 2. UNLAWFUL POSSESSION OF PILL PRESS MOLDS.

    (a) Prohibition.--Section 401 of the Controlled Substances Act (21 
U.S.C. 841) is amended by adding at the end the following:
    ``(i) Offense Regarding Unlawful Possession of Pill Press Molds.--
            ``(1) In general.--Whoever, with intent to manufacture in 
        violation of this title a counterfeit substance in schedule I 
        or II in a capsule, tablet, or other form for distribution, 
        knowingly possesses a pill press mold, shall be imprisoned not 
        more than 20 years and fined in accordance with title 18, 
        United States Code.
            ``(2) Definitions.--In this subsection, the term `pill 
        press mold' means any punch, die, plate, stone, or other object 
        designed to print, imprint, or reproduce on a controlled 
        substance (or the container or labeling thereof) the trademark, 
        trade name, or other identifying mark, imprint, number, or 
        device, or any likeness thereof, of a manufacturer, 
        distributor, or dispenser other than the person or persons who 
        in fact manufactured, created, distributed, or dispensed such 
        product, thereby rendering the controlled substance a 
        counterfeit substance.''.
    (b) Sentencing Guidelines.--Pursuant to the authority of the United 
States Sentencing Commission under section 994 of title 28, United 
States Code, and in accordance with this section, the United States 
Sentencing Commission shall review and amend, as appropriate, the 
Federal sentencing guidelines and policy statements to ensure that the 
guidelines provide for a penalty enhancement of not less than 2 offense 
levels above the offense level otherwise applicable for a violation of 
section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)) if 
the defendant is found, in connection with such violation of section 
401(a), to be in violation of section 401(i) of the Controlled 
Substances Act, as added by subsection (a).
                                 <all>